Regulus Therapeutics Inc. (RGLS)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
03-Jan-20 4:06 PM
View: 
Aker Christopher Ray
Sr. VP & General Counsel
Regulus Therapeutics Inc. (RGLS) 02-Jan-20Market Sale (Planned) 2,239$0.97$2,164.44(7%)
31.55K to 29.31K
(3%)
03-Jan-20 4:07 PM
View: 
Hagan Joseph P
President and CEO
Director
Regulus Therapeutics Inc. (RGLS) 02-Jan-20Market Sale (Planned) 8,345$0.97$8,067.11(3%)
243.43K to 235.08K
(3%)
15-Nov-19 5:36 PM
View: 
Hagan Joseph P
President and CEO
Director
Regulus Therapeutics Inc. (RGLS) 14-Nov-19Sale (Planned) 5,838$0.64$3,736.32(2%)
249.27K to 243.43K
15-Nov-19 5:37 PM
View: 
Aker Christopher Ray
Sr. VP & General Counsel
Regulus Therapeutics Inc. (RGLS) 14-Nov-19Sale (Planned) 833$0.64$533.12(3%)
32.38K to 31.55K
02-Oct-19 6:17 PM
View: 
Hagan Joseph P
President and CEO
Director
Regulus Therapeutics Inc. (RGLS) 01-Oct-19Sale (Planned) 8,743$0.68$5,968.85(3%)
258.01K to 249.27K
02-Oct-19 6:50 PM
View: 
Aker Christopher Ray
Sr. VP & General Counsel
Regulus Therapeutics Inc. (RGLS) 01-Oct-19Sale (Planned) 2,346$0.68$1,601.61(7%)
34.73K to 32.38K
16-Aug-19 4:16 PM
View: 
Aker Christopher Ray
Sr. VP & General Counsel
Regulus Therapeutics Inc. (RGLS) 15-Aug-19Sale (Planned) 899$0.55$494.99(3%)
35.62K to 34.73K
16-Aug-19 4:17 PM
View: 
Hagan Joseph P
President and CEO
Director
Regulus Therapeutics Inc. (RGLS) 15-Aug-19Sale (Planned) 4,375$0.55$2,408.88(2%)
262.38K to 258.01K
02-Jul-19 5:42 PM
View: 
Hagan Joseph P
President and CEO
Director
Regulus Therapeutics Inc. (RGLS) 01-Jul-19Private Sale (Planned) 5,783$1.31$7,584.40(2%)
268.17K to 262.38K
02-Jul-19 5:42 PM
View: 
Aker Christopher Ray
Sr. VP & General Counsel
Regulus Therapeutics Inc. (RGLS) 01-Jul-19Private Sale (Planned) 2,225$1.31$2,918.09(6%)
37.85K to 35.62K
02-Jul-19 5:41 PM
View: 
Chevallard Daniel R.
Chief Financial Officer
Regulus Therapeutics Inc. (RGLS) 01-Jul-19Private Sale (Planned) 2,669$1.31$3,500.39(3%)
80.54K to 77.87K
16-May-19 5:25 PM
View: 
Hagan Joseph P
President and CEO
Director
Regulus Therapeutics Inc. (RGLS) 16-May-19Market Sale (Planned) 39,352$1.22$47,966.20(13%)
307.52K to 268.17K
16-May-19 5:21 PM
View: 
Aker Christopher Ray
Sr. VP & General Counsel
Regulus Therapeutics Inc. (RGLS) 15-May-19Market Sale (Planned) 6,950$1.41$9,796.03(10%)
66.26K to 59.31K
16-May-19 5:21 PM
View: 
Chevallard Daniel R.
Chief Financial Officer
Regulus Therapeutics Inc. (RGLS) 15-May-19Market Sale (Planned) 10,000$1.41$14,089.00(11%)
90.54K to 80.54K
16-May-19 5:21 PM
View: 
Aker Christopher Ray
Sr. VP & General Counsel
Regulus Therapeutics Inc. (RGLS) 14-May-19Grant 38,512----139%
27.75K to 66.26K
16-May-19 5:21 PM
View: 
Chevallard Daniel R.
Chief Financial Officer
Regulus Therapeutics Inc. (RGLS) 14-May-19Grant 55,414----158%
35.13K to 90.54K
16-May-19 5:25 PM
View: 
Hagan Joseph P
President and CEO
Director
Regulus Therapeutics Inc. (RGLS) 14-May-19Grant 188,385----158%
119.13K to 307.52K
09-May-19 6:02 PM
View: 
Growth Equity Opportunities...
10% Owner
Regulus Therapeutics Inc. (RGLS) 07-May-19Private Purchase 1,136,700$1.08$1,227,640.00124%
915.75K to 2.05M
09-May-19 6:05 PM
View: 
Florence Anthony A. Jr.
10% Owner
Regulus Therapeutics Inc. (RGLS) 07-May-19Private Purchase
Duplicate
1,136,700$1.08$1,227,640.00124%
915.75K to 2.05M
08-May-19 5:13 PM
View: 
Papadopoulos Stelios
Director
Regulus Therapeutics Inc. (RGLS) 07-May-19Private Purchase 370,370$1.08$400,000.0045%
819.5K to 1.19M
09-May-19 6:06 PM
View: 
Mott David M
10% Owner
Regulus Therapeutics Inc. (RGLS) 07-May-19Private Purchase
Duplicate
1,136,700$1.08$1,227,640.00124%
915.75K to 2.05M
08-May-19 5:15 PM
View: 
Hagan Joseph P
President and CEO
Director
Regulus Therapeutics Inc. (RGLS) 07-May-19Private Purchase 33,194$1.08$35,849.50106%
31.35K to 64.54K
08-May-19 5:14 PM
View: 
Rastetter William H
Director
Regulus Therapeutics Inc. (RGLS) 07-May-19Private Purchase 92,889$1.08$100,320.00151%
61.33K to 154.22K
09-May-19 6:08 PM
View: 
Walker Paul Edward
10% Owner
Regulus Therapeutics Inc. (RGLS) 07-May-19Private Purchase
Duplicate
1,136,700$1.08$1,227,640.00124%
915.75K to 2.05M
09-May-19 6:02 PM
View: 
Barris Peter J
10% Owner
Regulus Therapeutics Inc. (RGLS) 07-May-19Private Purchase
Duplicate
1,136,700$1.08$1,227,640.00124%
915.75K to 2.05M
09-May-19 6:05 PM
View: 
Makhzoumi Mohamad
10% Owner
Regulus Therapeutics Inc. (RGLS) 07-May-19Private Purchase
Duplicate
1,136,700$1.08$1,227,640.00124%
915.75K to 2.05M
09-May-19 6:07 PM
View: 
Sandell Scott D
10% Owner
Regulus Therapeutics Inc. (RGLS) 07-May-19Private Purchase
Duplicate
1,136,700$1.08$1,227,640.00124%
915.75K to 2.05M
09-May-19 6:04 PM
View: 
Behbahani Ali
10% Owner
Regulus Therapeutics Inc. (RGLS) 07-May-19Private Purchase
Duplicate
1,136,700$1.08$1,227,640.00124%
915.75K to 2.05M
08-May-19 5:15 PM
View: 
Witz Pascale
Director
Regulus Therapeutics Inc. (RGLS) 07-May-19Private Purchase 29,630$1.08$32,000.40361%
8.22K to 37.85K
09-May-19 6:04 PM
View: 
Baskett Forest
10% Owner
Regulus Therapeutics Inc. (RGLS) 07-May-19Private Purchase
Duplicate
1,136,700$1.08$1,227,640.00124%
915.75K to 2.05M
09-May-19 6:06 PM
View: 
Makower Joshua
10% Owner
Regulus Therapeutics Inc. (RGLS) 07-May-19Private Purchase
Duplicate
1,136,700$1.08$1,227,640.00124%
915.75K to 2.05M
09-May-19 6:07 PM
View: 
Sonsini Peter W.
10% Owner
Regulus Therapeutics Inc. (RGLS) 07-May-19Private Purchase
Duplicate
1,136,700$1.08$1,227,640.00124%
915.75K to 2.05M
09-May-19 6:05 PM
View: 
Chang Carmen
10% Owner
Regulus Therapeutics Inc. (RGLS) 07-May-19Private Purchase
Duplicate
1,136,700$1.08$1,227,640.00124%
915.75K to 2.05M
03-Apr-19 4:15 PM
View: 
Aker Christopher Ray
Sr. VP & General Counsel
Regulus Therapeutics Inc. (RGLS) 01-Apr-19Market Sale (Planned) 2,710$0.98$2,659.05(30%)
9.0K to 6.29K
(9%)
03-Apr-19 4:16 PM
View: 
Chevallard Daniel R.
Chief Financial Officer
Regulus Therapeutics Inc. (RGLS) 01-Apr-19Market Sale (Planned) 3,253$0.98$3,192.49(26%)
12.63K to 9.37K
(9%)
03-Apr-19 4:31 PM
View: 
Hagan Joseph P
President and CEO
Director
Regulus Therapeutics Inc. (RGLS) 01-Apr-19Market Sale (Planned) 5,842$0.98$5,731.00(16%)
37.19K to 31.35K
(9%)
06-Feb-19 4:49 PM
View: 
Aker Christopher Ray
Sr. VP & General Counsel
Regulus Therapeutics Inc. (RGLS) 05-Feb-19Grant 25,000----910%
2.75K to 27.75K
06-Feb-19 4:50 PM
View: 
Chevallard Daniel R.
Chief Financial Officer
Regulus Therapeutics Inc. (RGLS) 05-Feb-19Grant 30,000$0.95$28,500.00655%
4.58K to 34.58K
5%
06-Feb-19 4:51 PM
View: 
Hagan Joseph P
President and CEO
Director
Regulus Therapeutics Inc. (RGLS) 05-Feb-19Grant 65,000$0.95$61,750.00339%
19.15K to 84.15K
5%
06-Feb-19 4:52 PM
View: 
Wright Timothy Michael
Chief R & D Officer
Regulus Therapeutics Inc. (RGLS) 05-Feb-19Grant 40,000$0.95$38,000.00175%
22.89K to 62.89K
5%
02-Jan-19 4:12 PM
View: 
Papadopoulos Stelios
Director
Regulus Therapeutics Inc. (RGLS) 28-Dec-18Market Purchase 50,000$1.09$54,570.006%
785.07K to 835.07K
(8%)
28-Dec-18 4:21 PM
View: 
Papadopoulos Stelios
Director
Regulus Therapeutics Inc. (RGLS) 27-Dec-18Market Purchase 26,401$1.04$27,459.703%
758.67K to 785.07K
(3%)
28-Dec-18 4:21 PM
View: 
Papadopoulos Stelios
Director
Regulus Therapeutics Inc. (RGLS) 26-Dec-18Market Purchase 90,000$0.95$85,878.0013%
668.67K to 758.67K
5%
19-Nov-18 4:01 PM
View: 
Collier Kathryn J
Director
Regulus Therapeutics Inc. (RGLS) 16-Nov-18Market Purchase 7,100$1.41$10,011.0035%
20.5K to 27.6K
(29%)
19-Nov-18 4:03 PM
View: 
Papadopoulos Stelios
Director
Regulus Therapeutics Inc. (RGLS) 16-Nov-18Market Purchase 300,000$1.38$415,470.0081%
368.67K to 668.67K
(28%)
19-Nov-18 4:03 PM
View: 
Papadopoulos Stelios
Director
Regulus Therapeutics Inc. (RGLS) 15-Nov-18Market Purchase 200,000$1.33$265,080.00119%
168.67K to 368.67K
(25%)
13-Nov-18 5:33 PM
View: 
Rastetter William H
Director
Regulus Therapeutics Inc. (RGLS) 12-Nov-18Grant 23,258----41%
56.41K to 79.67K
13-Nov-18 5:35 PM
View: 
Baltimore David
Director
Regulus Therapeutics Inc. (RGLS) 12-Nov-18Grant 40,339----1064%
3.79K to 44.13K
21-Nov-18 5:29 PM
View: 
Papadopoulos Stelios
Director
Regulus Therapeutics Inc. (RGLS) 12-Nov-18Grant 20,910----14%
147.76K to 168.67K
13-Nov-18 5:32 PM
View: 
Rosen Hugh
Director
Regulus Therapeutics Inc. (RGLS) 12-Nov-18Grant 19,245----548%
3.51K to 22.76K